Evidence map›Paper›PMID 26650489›Full record

ArticleInflammation2016

Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production.

Miao-Wu Dong, Ming Li, Jie Chen, Tong-Tong Fu, Ke-Zhi Lin, Guang-Hua Ye, Jun-Ge Han, Xiang-Ping Feng, Xing-Biao Li, Lin-Sheng Yu and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Multi-target healing mechanisms ofAvicenna journal of phytomedicine · 2026
    Article
  5. Review
  6. Article
  7. Frontiers in pharmacology · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Topical nicotinic receptor activation improves wound bacterial infection outcomes and TLR2-mediated inflammation in diabetic mouse wounds.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Miao-Wu DongCenter of Basic Medical Experiment, School of Basic Medical Science, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Ming LiRenji College, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Jie ChenRenji College, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Tong-Tong FuRenji College, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Ke-Zhi LinCenter of Basic Medical Experiment, School of Basic Medical Science, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Guang-Hua YeDepartment of Forensic Medicine, School of Basic Medical Science, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Jun-Ge HanDepartment of Forensic Medicine, School of Basic Medical Science, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Xiang-Ping FengDepartment of Forensic Medicine, School of Basic Medical Science, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Xing-Biao LiDepartment of Forensic Medicine, School of Basic Medical Science, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Lin-Sheng YuDepartment of Forensic Medicine, School of Basic Medical Science, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China.
Yan-Yan FanDepartment of Forensic Medicine, School of Basic Medical Science, Wenzhou Medical University, Higher Education District, Wenzhou, Zhejiang Province, 325035, People's Republic of China. yyfan998@163.com.
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes frequently presents accumulation of advanced glycation end products (AGEs), which might induce excessive TNF-α production from macrophages to cause impaired wound healing. Recent studies have shown that activation of α7 nicotinic acetylcholine receptor (α7nAChR) on macrophages efficiently suppressed TNF-α synthesis. The aim of this study was to investigate the accumulation of AGEs in the wounds and determine whether PNU282987, an α7nAChR agonist, can improve wound repair by inhibiting AGE-mediated TNF-α production in a streptozotocin (STZ)-induced diabetic mouse model. Animals were assigned into four groups: wounded control group, wounded diabetic group, wounded diabetic group treated intraperitoneally with PNU282987, or wounded diabetic group treated intraperitoneally with vehicle. Compared with the non-diabetic control mice, the diabetic mice exhibited delayed wound healing that was characterized by elevated accumulation of AGEs, increased TNF-α level and macrophage infiltration, and decreased fibroblast number and collagen deposition at the late stage of repair. Besides, macrophages of diabetic wounds showed expression of α7nAChR. During late repair, PNU282987 treatment of diabetic mice significantly reduced the level of TNF-α, accelerated wound healing, and elevated fibroblast number and collagen deposition. To investigate the cellular mechanism of these observations, RAW 264.7 cells, a macrophage cell line, were incubated with AGEs in the presence or absence of PNU282987. TNF-α production from AGE-stimulated macrophages was significantly decreased by PNU282987 in a dose-dependent manner. Furthermore, PNU282987 significantly inhibited AGE-induced nuclear factor-κB (NF-κB) activation and receptor for AGE (RAGE) expression. These results strongly suggest that activating α7nAChR can promote diabetic wound healing by suppressing AGE-induced TNF-α production, which may be closely associated with the blockage of NF-κB activation in macrophages.

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorAnimalsBenzamidesBridged Bicyclo CompoundsCell LineDiabetes Mellitus, ExperimentalEnzyme ActivationGlycation End Products, AdvancedMacrophagesMaleMiceMice, Inbred ICRReceptor for Advanced Glycation End ProductsTranscription Factor RelATumor Necrosis Factor-alphaWound HealingAger protein, mousealpha7 Nicotinic Acetylcholine ReceptorBenzamidesBridged Bicyclo CompoundsGlycation End Products, AdvancedPNU-282987Receptor for Advanced Glycation End ProductsRela protein, mouseTranscription Factor RelATumor Necrosis Factor-alphaAGEsdiabetesmacrophageTNF-αwound healingα7nAChR

Identifiers

PMID26650489
OpenAlexW2291121016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.